Prof. Andrea Cusumano, M.D. who is carrying out his research and teaching activity in Ophthalmology in Italy at Rome Tor Vergata University, strong of an international ophthalmologic and teaching background, has kept his academic and teaching engagements abroad transferring in real time into the clinical and surgical practice the most advanced technologies deriving from the most prestigious ophthalmological schools. He is currently vested with the following appointments: APL Ophthalmology Professor at the Rheinische Friederich-Wilhelms Universität in Bonn, Adjunct Associate Professor at Weill Medical College of Cornell University in New York, Founder and President of a Scientific Committee of the Italian-German Foundation DISAHF for the Ophthalmologic Neurologic Research, a joint Foundation of the Alexander von Umboldt Foundation.
On the basis of the above-mentioned experiences and relations he has been lately involved in the new ambitious project of the Macula & Genoma Foundation Onlus, a No-Profit Organization principally oriented to the sponsoring of the basic research, the dissemination of the data deriving from it and the presentation of new diagnostic and clinical surgical techniques of the eye pathologies having greater social relevance for the patients, the medical operators and the media.
Considered an international opinion-leader of the sector, his participations in medical formation programs, often in the dissemination spaces of the Italian Ministry of Health and his interviews given to the principal national and international newspapers, are very frequent.
Being a lover of visual arts with a passion for painting, he discovered that in some of the paintings of Van Gogh, and, in particular, in the famous “Church in Auvers-sur-Oise”, distorted lines can be seen that are similar to those described by patients in the acute phase of the central serous chorioretinopathy (CSCR). In several interviews given to the press and in others broadcasted on Italian TV Channels (link “Indovina cosa vedeva Van Gogh [Guess what was Van Gogh seeing]” – “Van Gogh e la Retinopatia [Van Gogh and Retinopathy]” –“Le Storie Diario Italiano” [Italian Diary Stories]) and on other television channels, Prof. Cusumano explains that Van Gogh represents the first documented patient in which the typical signs of this pathology caused by stress, which is rather widespread “as of today’s date”, were already present at the time of the peak of his inner distress, shortly before his death.
Among his latest projects, the one in which he was most involved was the realization of an Ophthalmologic Center in Italy (Rome Vision Clinic) open to experts coming from all over the world and in which a new generation of ophthalmologists is able to put at disposal of everybody his/her specific talent and exclusive knowledge aimed at improving in the clinical practice the medical surgical treatment of the patients suffering from eye pathologies.
His attention to cutting edge technologies and methods and his direct and/or indirect participation in cross-national research programs led him to implement in the ophthalmologic framework the eye genetics, the pharmacogenomics (Santa Lucia Foundation), the gene therapy, the optogenetics and the optopharmacology, the stem cells and retinal prostheses.